DanCann Pharma Feed

Land	Danmark
Lista	Spotlight DK
Sektor	Hälsovård
Industri	Läkemedel & Handel

2024-04-17 12:00:00 DanCann Pharma A/S: MINUTES OF EXTRAORDINARY GENERAL MEETING +0,82% | 0,01 MDKK

2024-04-02 22:30:00 DanCann Pharma: NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S -5,03% | 0,08 MDKK

2024-03-30 10:15:00 Correction: DanCann Pharma A/S intends to initiate and complete a partly secured rights issue of up to DKK 18.5 million to restructure, strengthen and secure a debt-free capital structure -47,77% | 0,73 MDKK

2024-03-29 13:00:00 DanCann Pharma A/S intends to initiate and complete a partly secured rights issue of up to DKK 18.5 million to restructure, strengthen and secure a debt-free capital structure -47,77% | 0,73 MDKK

2024-02-28 10:30:00 DanCann Pharma A/S: Germany makes historic move towards cannabis reclassification and legalization +13,86% | 0,34 MDKK

2024-02-28 08:30:00 DanCann Pharma A/S Reports Fourth Quarter and Full Year 2023 Results +13,86% | 0,34 MDKK

2024-01-10 22:30:00 DanCann Pharma A/S Completes Issuance (8) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2 0,00% | 0,10 MDKK

2023-12-20 09:00:00 DanCann Pharma A/S delivers annual shareholder letter and investor update -3,85% | 0,03 MDKK

2023-11-30 18:10:00 DanCann Pharma A/S: Flagging announcement +2,22% | 0,04 MDKK

2023-11-30 18:00:00 DanCann Pharma A/S publishes Q3-2023 report +2,22% | 0,04 MDKK

2023-11-28 22:00:00 DanCann Pharma A/S Completes Issuance (7) of New Shares under the Loan-Agreement with Nordic Growth Opportunities 2 - Marking a Milestone with a Conversion Rate Exceeding 50 percent of Tranche 1 0,00% | 0,02 MDKK

2023-11-22 21:30:00 DanCann Pharma A/S Completes Issuance (6) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2 -14,58% | 0,05 MDKK

2023-10-26 17:30:00 DanCann Pharma A/S: Future strategic direction -7,35% | 0,06 MDKK

2023-10-04 08:00:00 DanCann Pharma A/S Completes Issuance (5) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2 -8,16% | 0,18 MDKK

2023-10-02 13:00:00 DanCann Pharma A/S sigter mod at accelerere forretnings- og indtægtsvækst: Omfattende strategiopdatering følger i oktober +31,71% | 0,25 MDKK

2023-10-02 13:00:00 DanCann Pharma A/S aims to accelerate business and revenue growth: Comprehensive strategy update to follow in October +31,71% | 0,25 MDKK

2023-09-26 08:45:00 DanCann Pharma A/S Completes Issuance (4) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2 +2,67% | 0,02 MDKK

2023-08-31 21:00:00 DanCann Pharma A/S Completes Issuance (3) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2 -25,93% | 0,38 MDKK

2023-08-31 17:30:00 DanCann Pharma A/S publishes Q2-2023 report -25,93% | 0,38 MDKK

2023-08-31 08:30:00 DanCann Pharma A/S to refocus its strategy - will reinvigorate its pipeline and product portfolio, and start looking for future owner or partnership for BP1 -49,06% | 1,10 MDKK

2023-08-18 20:00:00 Correction: DanCann Pharma A/S Completes Issuance (2) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2 -0,53% | 0,15 MDKK

2023-08-18 18:00:00 DanCann Pharma A/S Completes Issuance (2) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2 -0,53% | 0,15 MDKK

2023-07-27 23:00:00 DanCann Pharma A/S Completes Issuance of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2 -5,24% | 0,35 MDKK

2023-07-17 18:00:00 DanCann Pharma A/S Successfully Receives First Tranche from the 10-Year Financing Loan-Agreement with 12-months Conversion Option and Warrants with Nordic Growth Opportunities 2 -0,40% | 0,22 MDKK

2023-06-20 12:50:00 DanCann Pharma A/S: MINUTES OF EXTRAORDINARY GENERAL MEETING -0,39% | 0,22 MDKK

2023-06-02 18:00:00 DanCann Pharma A/S: NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S -3,33% | 0,13 MDKK

2023-06-02 17:20:00 DanCann Pharma A/S Secures 10-Year Financing Loan-Agreement with 12-months Conversion Option and Warrants +8,03% | 0,16 MDKK

2023-06-02 17:15:00 DanCann Pharma receives approximately DKK 5.6 million from the exercise of series TO 2 together with a directed issue to the underwriters +8,03% | 0,16 MDKK

2023-06-01 09:00:00 DanCann Pharma A/S' Pre-Validation Batches Meets European Standards, paving the Path for Final Product Approval +0,28% | 0,05 MDKK

2023-05-31 18:00:00 DanCann Pharma A/S publishes Q1-2023 report +0,28% | 0,05 MDKK

2023-05-30 12:00:00 DanCann Pharma A/S: MINUTES OF ANNUAL GENERAL MEETING +4,59% | 0,06 MDKK

2023-05-26 08:30:00 DanCann Pharma A/S has secured 71 percent of the TO 2's -7,50% | 0,24 MDKK

2023-05-26 08:15:00 DanCann Pharma A/S has successfully completed pre-validation batches and expects final approval from the Danish Medicines Agency by the end of summer -7,50% | 0,24 MDKK

2023-05-26 08:00:00 DanCann Pharma A/S in advanced talks with new investor of additional DKK 12 million for topping up the outcome of the TO 2's -7,50% | 0,24 MDKK

2023-05-24 09:42:16 Correction: DanCann Pharma A/S invites to an investor presentation and Q&A session in relation to ongoing exercise period of warrants 0,00% | 0,10 MDKK

2023-05-24 09:00:00 DanCann Pharma A/S invites to an investor presentation and Q&A session in relation to ongoing exercise period of warrants 0,00% | 0,10 MDKK

2023-05-16 09:00:00 DanCann Pharma A/S: The exercise period for warrants of series TO 2 begins today -16,87% | 0,39 MDKK

2023-05-15 17:00:00 DanCann Pharma A/S: The subscription price for warrants of series TO 2 has been set -3,76% | 0,14 MDKK

2023-05-12 09:05:00 DanCann Pharma A/S is strengthening its regulatory focus by appointing a life science lawyer to the board of directors -1,56% | 0,14 MDKK

2023-05-12 09:05:00 DanCann Pharma A/S styrker sit regulatoriske fokus med indstilling af life science-advokat til bestyrelsen -1,56% | 0,14 MDKK

2023-05-12 08:50:00 DanCann Pharma: NOTICE OF ANNUAL GENERAL MEETING 2023 IN DANCANN PHARMA A/S -1,56% | 0,14 MDKK

2023-05-12 08:45:00 DanCann Pharma A/S publishes Annual Report 2022 -1,56% | 0,14 MDKK

2023-05-09 09:00:00 DanCann Pharma A/S has signed an exclusive contract with MYCB1 GmbH for the distribution of full-spectrum extracts based on Bedrocan International varieties -4,14% | 0,09 MDKK

2023-04-20 20:00:00 Correction: DanCann Pharma A/S is reducing its debt with current lenders through a share issue by conversion of debt at market conditions +4,76% | 0,02 MDKK

2023-04-03 08:00:00 DanCann Pharma A/S præsenterede deres arbejde for Udenrigsministeriet -2,15% | 0,14 MDKK

2023-04-03 08:00:00 DanCann Pharma A/S presented their work to the Ministry of Foreign Affairs -2,15% | 0,14 MDKK

2023-03-21 08:00:00 DanCann Pharma A/S is reducing its debt with current lenders through a directed share issue at market conditions -10,75% | 0,35 MDKK

2023-03-14 08:30:00 DanCann Pharma A/S Provides Positive Insight on Progress of Cannabis Bulk Product Approval +12,55% | 0,36 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2024-08-30	Kvartalsrapport 2024-Q2
2024-05-31	Kvartalsrapport 2024-Q1
2024-05-30	Årsstämma 2024
2024-04-22	Ordinarie utdelning DANCAN 0.00 DKK
2024-04-17	Extra Bolagsstämma 2024
2024-02-28	Bokslutskommuniké 2023
2023-11-30	Kvartalsrapport 2023-Q3
2023-08-31	Kvartalsrapport 2023-Q2
2023-05-31	Kvartalsrapport 2023-Q1
2023-04-19	Ordinarie utdelning DANCAN 0.00 DKK
2023-04-18	Årsstämma 2023
2023-02-28	Bokslutskommuniké 2022
2022-11-04	Kvartalsrapport 2022-Q3
2022-09-20	Extra Bolagsstämma 2022
2022-08-31	Kvartalsrapport 2022-Q2
2022-05-18	Kvartalsrapport 2022-Q1
2022-04-27	Årsstämma 2022
2022-04-08	Ordinarie utdelning DANCAN 0.00 DKK
2022-02-25	Bokslutskommuniké 2021
2021-11-26	Kvartalsrapport 2021-Q3
2021-08-27	Kvartalsrapport 2021-Q2
2021-07-23	Extra Bolagsstämma 2021
2021-05-28	Kvartalsrapport 2021-Q1
2021-04-29	Ordinarie utdelning DANCAN 0.00 DKK
2021-04-28	Årsstämma 2021
2021-02-26	Bokslutskommuniké 2020

DanCann Pharma

Kalender

Beskrivning

DanCann Pharma

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden